PFE Jan 2024 60.000 call
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 01:00PM EDT. Market open.
| Previous Close | 2.9700 |
| Open | 2.9300 |
| Bid | 2.9500 |
| Ask | 3.1000 |
| Strike | 60.00 |
| Expire Date | 2024-01-19 |
| Day's Range | 2.9300 - 2.9800 |
| Contract Range | N/A |
| Volume | |
| Open Interest | 9.12k |
- Editor's PickYahoo Finance Video
UK approves COVID vaccine that targets Omicron subvariants
Yahoo Finance reporter Anjalee Khemlani details how the U.K. has approved a vaccine that targets both the original and omicron variants of the coronavirus.
- Motley Fool
1 Hot Growth Stock to Buy, and 1 to Avoid (For Now)
On that note, Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) worked together to develop and commercialize their coronavirus vaccine, Comirnaty. In BioNTech's second quarter, practically 100% of its product sales, totaling around $3.3 billion, were attributable to its share of jab revenue.
- Zacks
Novavax's (NVAX) COVID Vaccine Aids Growth, Overdependence Ails
Currently, Novavax (NVAX) has only one marketed product in its portfolio, its protein-based COVID-19 vaccine. However, it is lagging in competition behind mRNA-based vaccines.
© 2022 Yahoo. All rights reserved.
